Related Experiment Videos
E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal
A J Dicker1, C Popa, A L Dahler
1Epithelial Pathobiology Group, Centre for Immunology and Cancer Research, University of Queensland Department of Medicine, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia.
Abstract:
Squamous differentiation of keratinocytes is associated with decreases in E2F-1 mRNA expression and E2F activity, and these processes are disrupted in squamous cell carcinoma cell lines. We now show that E2F-1 mRNA expression is increased in primary squamous cell carcinomas of the skin relative to normal epidermis. To explore the relationship between E2F-1 and squamous differentiation further, we examined the effect of altering E2F activity in primary human keratinocytes induced to differentiate. Promoter activity for the proliferation-associated genes, cdc2 and keratin 14, are inhibited during squamous differentiation. This inhibition can be inhibited by overexpression of E2F-1 in keratinocytes. Overexpression of E2F-1 also suppressed the expression of differentiation markers (transglutaminase type 1 and keratin 10) in differentiated keratinocytes. Blocking E2F activity by transfecting proliferating keratinocytes with dominant negative E2F-1 constructs inhibited the expression of cdc2 and E2F-1, but did not induce differentiation. Furthermore, expression of the dominant negative construct in epithelial carcinoma cell lines and normal keratinocytes decreased expression from the cdc2 promoter. These data indicate that E2F-1 promotes keratinocyte proliferation-specific marker genes and suppresses squamous differentiation-specific marker genes. Moreover, these data indicate that targeted disruption of E2F-1 activity may have therapeutic potential for the treatment of squamous carcinomas. Oncogene (2000).
Insights
E2F-1 promotes keratinocyte proliferation and suppresses squamous differentiation. Targeting E2F-1 activity may offer a therapeutic strategy for squamous cell carcinomas.
Area of Science:
- Cell biology
- Molecular oncology
- Dermatology
Background:
- Squamous differentiation involves decreased E2F-1 mRNA and activity, processes often disrupted in squamous cell carcinoma.
- E2F-1 mRNA expression is elevated in primary skin squamous cell carcinomas compared to normal epidermis.
Purpose of the Study:
- To investigate the role of E2F-1 in keratinocyte squamous differentiation.
- To explore the therapeutic potential of targeting E2F-1 in squamous cell carcinoma.
Main Methods:
- Examined E2F-1 effects by altering E2F activity in differentiating primary human keratinocytes.
- Utilized dominant-negative E2F-1 constructs in keratinocytes and carcinoma cell lines.
- Assessed promoter activity of proliferation and differentiation markers (cdc2, keratin 14, transglutaminase type 1, keratin 10).
Main Results:
- Overexpression of E2F-1 inhibited proliferation markers (cdc2, keratin 14) and suppressed differentiation markers (transglutaminase type 1, keratin 10).
- Blocking E2F activity suppressed cdc2 and E2F-1 expression but did not induce differentiation.
- Dominant-negative E2F-1 decreased cdc2 promoter activity in both normal keratinocytes and carcinoma cell lines.
Conclusions:
- E2F-1 promotes keratinocyte proliferation markers and inhibits squamous differentiation markers.
- Disrupting E2F-1 activity shows potential therapeutic value for treating squamous cell carcinomas.